The strategy of GLP-1RAs combined with non-pharmacological therapy for improving sarcopenia Given that the weight loss effect induced by GLP-1RAs is often accompanied by the risk of muscle loss, and this influence is regulated by multiple factors such as age, underlying diseases, and the duration of treatment, in order to retain muscle mass to the greatest extent, the clinical consensus suggests that GLP-1RA treatment must be combined with active non-pharmacological intervention
Studies in Annals of the New York Academy of Sciences have referenced Epithalon within broader research into bioregulator peptides and longevity science Note: All cited research refers to laboratory and animal model studies
In this blog, we will break down how GLP-1 medications may influence energy availability, muscle mass, workout performance, and recovery timelines, and what active adults can do to protect performance while still reaching their weight loss goals
The brand is looking at product extensions for specific nutrient needs like fiber, protein, and collagen, Rankin added
If I get a tattoo, what should I know